Antibacterial Properties of Bacteriocin Purified from Serratia marcescens and Computerized Assessment of its Interaction with Antigen 43 in Escherichia coli

Document Type : Original Articles

Authors

Department of Marine Biotechnology, Khorramshahr University of Marine Science and Technology, Khorramshahr, Iran

10.32592/ARI.2023.78.6.1738

Abstract

Bacteriocins are a kind of antimicrobial peptides that kill or inhibit the growth of bacterial strains. The purpose of this study was to investigate the antibacterial effect of Serratia marcescens on several pathogenic bacterial strains. Bacteriocin produced by S. marcescens was purified by chromatography with Sephadex G-75 column, and its antibacterial effect on gram-negative bacteria, including Escherichia coli ATCC 700928, Pseudomonas aeruginosa PTCC 1707, S. marcescens PTCC 1621, Vibrio fischeri PTCC 1693, and Vibrio harveyi PTCC 1755, were evaluated by the disk diffusion method. The structure of bacteriocin was determined by nuclear magnetic resonance spectroscopy. The interaction of bacteriocin with the antigen 43 (Ag43) of E. coli was evaluated by the molecular docking method. Bacteriocin extracted from bacterial isolates had antibacterial activity on E. coli strains but not on other studied strains. Bioinformatics analysis also showed bacteriocin docking with Ag43 with an energy of -159.968 kJ/mol. Natural compounds, such as bacteriocin, can be an alternative to common chemical compounds and antibiotics. To reach a definite conclusion in this regard, there is a need for further research and understanding of their mechanism of action.

Keywords

Main Subjects


References
1. Bemena LD, Mohamed LA, Fernandes AM, Lee BH.
Applications of bacteriocins in food, livestock health
and medicine. Int J Curr Microbiol App Sci.
2014;3(12):924-49.
2. Negash AW, Tsehai BA. Current Applications of
Bacteriocin. International Journal of Microbiology.
2020;2020.
3. Andersson DI, Balaban NQ, Baquero F, Courvalin P,
Glaser P, Gophna U, et al. Antibiotic resistance: turning
evolutionary principles into clinical reality. FEMS
microbiology reviews. 2020;44(2):171-88.
4. Rajaram G, Manivasagan P ,Thilagavathi B,
Saravanakumar A. Purification and characterization of a
bacteriocin produced by Lactobacillus lactis isolated
from marine environment. Advance Journal of food
science and technology. 2010;2(2):138-44.
5. Jamaluddin N, Stuckey DC, Ariff AB ,Faizal Wong
FW. Novel approaches to purifying bacteriocin: A
review. Critical reviews in food science and nutrition.
2018;58(14):2453-65.
6. Kamarajan P, Hayami T, Matte B, Liu Y, Danciu T,
Ramamoorthy A, et al. Nisin ZP, a bacteriocin and food
1744 Mousavi SM et al / Archives of Razi Institute, Vol. 78, No. 6 (2023) 1738-1745
preservative, inhibits head and neck cancer
tumorigenesis and prolongs survival. PloS one.
2015;10(7):e0131008.
7. Mathur H, Field D, Rea MC, Cotter PD, Hill C, Ross
RP. Bacteriocin-antimicrobial synergy: a medical and
food perspective. Frontiers in Microbiology.
2017;8:1205.
8. O’Connor PM, Ross RP, Hill C, Cotter PD.
Antimicrobial antagonists against food pathogens: a
bacteriocin perspective. Current Opinion in Food
Science. 2015;2:51-7.
9. Ahmad V, Khan MS, Jamal QMS, Alzohairy MA, Al
Karaawi MA, Siddiqui MU .Antimicrobial potential of
bacteriocins: in therapy, agriculture and food
preservation. International Journal of Antimicrobial
Agents. 2017;49(1):1-11.
10.Chikindas ML, Weeks R, Drider D, Chistyakov VA,
Dicks LM. Functions and emerging applications of
bacteriocins. Current opinion in biotechnology.
2018;49:23-8.
11. Yi L, Dang J, Zhang L, Wu Y, Liu B, Lü X.
Purification, characterization and bactericidal
mechanism of a broad spectrum bacteriocin with
antimicrobial activity against multidrug-resistant strains
produced by Lactobacillus coryniformis XN8. Food
Control. 2016;67:53-62.
12. Arabestani MR, Mousavi SM, Alikhani MY.
Bacteriocins as the alternatives to antibiotics. Avicenna
J Clin Microbiol Infect, doi. 2014;10.
13. Khandelwal P, Upendra RS. Bacteriocins from Bugs of
Millennium: Uses, Potential and Prospects in Food
Industry. International Journal of Fermented Foods.
2017;6(2):97.
14. Acedo JZ, Chiorean S, Vederas JC, van Belkum MJ.
The expanding structural variety among bacteriocins
from Gram-positive bacteria. FEMS microbiology
reviews. 2018;42(6):805-28.
15. Grimont P, Grimont F. Enterobacter, p 1–17. Bergey’s
manual of systematics of archaea and bacteria John
Wiley & Sons, Ltd, New York, NY. 2015.
16. Mousavi SM, Archangi B, Zolgharnein H, Zamani I.
Biocolorant “prodigiosin” interferes with the growth of
biofouling bacteria: an in vitro and in silico approach.
Pigment & Resin Technology. 2021. 1;51(1):24-32.
17. Foulds J. Purification and partial characterization of a
bacteriocin from Serratia marcescens. Journal of
bacteriology. 1972;110(3):1001-9.
18. Foulds JD, Shemin D. Properties and characteristics of a
bacteriocin from Serratia marcescens. Journal of
bacteriology. 1969;99(3):655-60.
19. 19. Graham CE, Cruz MR, Garsin DA, Lorenz MC.
Enterococcus faecalis bacteriocin EntV inhibits hyphal
morphogenesis, biofilm formation, and virulence of
Candida albicans. Proceedings of the National
Academy of Sciences. 2017;114(17):4507-12.
20. Malathi V, Selvakumar D. Bacteriocin Production by
Lactococcus lactis MTCC 440 .Indian Journal of
Applied Microbiology. 2016;19(2):43-51.
21. Quereda JJ, Dussurget O, Nahori M-A, Ghozlane A,
Volant S, Dillies M-A, et al. Bacteriocin from epidemic
Listeria strains alters the host intestinal microbiota to
favor infection. Proceedings of the National Academy
of Sciences. 2016;113(20):5706-11.
22. Todorov S, de Melo Franco B, Tagg J. Bacteriocins of
Gram-positive bacteria having activity spectra
extending beyond closely-related species. Beneficial
microbes. 2019;10(3):315-28.
23. Prudêncio CV, Dos Santos MT, Vanetti MCD.
Strategies for the use of bacteriocins in Gram-negative
bacteria: relevance in food microbiology. Journal of
food science and technology. 2015;52(9):5408-17.
24.Rebuffat S. Bacteriocins from Gram-negative bacteria: a
classification? Prokaryotic antimicrobial peptides:
Springer; 2011. p. 55-72.
25. Li P, Kwok AH, Jiang J, Ran T, Xu D, Wang W, et al.
Comparative genome analyses of Serratia marcescens
FS14 reveals its high antagonistic potential. PLoS One.
2015;10(4):e01.23061.
26. Foulds J. Mode of action of a bacteriocin from Serratia
marcescens. Journal of bacteriology. 1971;107(3):833-9.
27. Yuriev E, Holien J, Ramsland PA. Improvements,
trends, and new ideas in molecular docking: 2012–2013
in review. Journal of Molecular Recognition.
2015;28(10):581-604.
28. Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin
TE. A geometric approach to macromolecule-ligand
interactions. Journal of molecular biology. 1982;
161(2):269-88.
29. Amaro RE, Baudry J, Chodera J, Demir Ö, McCammon
JA, Miao Y, et al. Ensemble docking in drug discovery.
Biophysical journal. 2018;114(10):2271-8.
30. Heras B, Totsika M, Peters KM, Paxman JJ, Gee CL,
Jarrott RJ, et al. The antigen 43 structure reveals a
molecular Velcro-like mechanism of autotransportermediated bacterial clumping. Proceedings of the
National Academy of Sciences. 2014;111(1):457-62.
Mousavi SM et al / Archives of Razi Institute, Vol. 78, No. 6 (2023) 1738-1745 1745
31. Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo J-M,
Schembri MA. Functional analysis of antigen 43 in
uropathogenic Escherichia coli reveals a role in longterm persistence in the urinary tract. Infection and
immunity. 2007;75(7):3233-44.
32. Henderson IR, Meehan M, Owen P. Antigen 43, a
phase-variable bipartite outer membrane protein,
determines colony morphology and autoaggregation in
Escherichia coli K-12. FEMS microbiology letters.
1997;149(1):115-20.
33. Danese PN, Pratt LA, Dove SL, Kolter R. The outer
membrane protein, antigen 43, mediates cell‐to‐cell
interactions within Escherichia coli biofilms. Molecular
microbiology. 2000;37(2):424-32.
34. Klemm P, Hjerrild L, Gjermansen M, Schembri MA.
Structure‐function analysis of the self‐recognizing
Antigen 43 autotransporter protein from Escherichia
coli. Molecular microbiology. 2004;51(1):283-96.